Concepedia

Anasuya Gunturi

AG

8

Publications

534

Citations

8

H-Index

1999

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Beth Israel Deaconess Medical Center

Massachusetts General Hospital

The University of Texas Southwestern Medical Center

University of Pittsburgh

Anasuya Gunturi is an author at Dana-Farber Cancer Institute specializing in oncology, radiation oncology, and cancer research.

Top concepts

Publications per year

1999–2024

8

Publications

8

Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors

A. B. Ackerman, Oliver Klein, David F. McDermott et al. · Cancer · 2014 · 223 citations

Cutting Edge: Expression of Functional CD94/NKG2A Inhibitory Receptors on Fetal NK1.1+Ly-49− Cells: A Possible Mechanism of Tolerance During NK Cell Development

Pallavur V. Sivakumar, Anasuya Gunturi, Margarita Salcedo et al. · The Journal of Immunology · 1999 · 81 citations

Preferential Survival of CD8 T and NK Cells Expressing High Levels of CD94

Anasuya Gunturi, Rance E. Berg, James Forman · The Journal of Immunology · 2003 · 77 citations · Full text

The role of TCR stimulation and TGF‐β in controlling the expression of CD94/NKG2A receptors on CD8 T cells

Anasuya Gunturi, Rance E. Berg, Emily Crossley et al. · European Journal of Immunology · 2005 · 43 citations · Full text

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma

Elizabeth I. Buchbinder, Anasuya Gunturi, Jessica Perritt et al. · Journal for ImmunoTherapy of Cancer · 2016 · 43 citations · Full text

Rows per page

1–5 of 8